InterventionsHumans
Early urate-lowering therapy and cardiometabolic risk in adults without documented major cardiometabolic disease: a real-world cohort study

Frontiers in Endocrinology
- Urate-lowering therapy
- Xanthine oxidase inhibitors
- Hyperuricemia
- Composite cardiometabolic outcome
- Uric acid
- Humans
The paper
Huo AP, Wang SI, Leong PY et al.
Frontiers in Endocrinology · 31 Aug 2026

